I am upgrading STERIS to a 'Buy' with a fair value of $240 per share due to the recent stock price pullback and solid growth prospects. STERIS reported 7.2% organic revenue growth and 5.4% adjusted ...
Steven Madden, Ltd. delivered strong Q4 '25 top line results, especially in owned brands, but margins remain pressured and private label continues to decline. Despite positive 2026 top line guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results